|
PRR11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.65103519534205E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14270037876452E-10 |
| Normal-vs-Stage2 |
2.777300E-04 |
| Normal-vs-Stage3 |
1.38570000030036E-07 |
| Normal-vs-Stage4 |
1.361830E-04 |
| Stage1-vs-Stage2 |
5.798600E-01 |
| Stage1-vs-Stage3 |
2.667200E-01 |
| Stage1-vs-Stage4 |
4.213500E-02 |
| Stage2-vs-Stage3 |
2.159000E-01 |
| Stage2-vs-Stage4 |
3.409500E-02 |
| Stage3-vs-Stage4 |
1.383150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78324022215293E-12 |
| Normal-vs-AfricanAmerican |
5.987900E-02 |
| Normal-vs-Asian |
1.293430E-01 |
| Caucasian-vs-AfricanAmerican |
4.800100E-04 |
| Caucasian-vs-Asian |
2.873800E-01 |
| AfricanAmerican-vs-Asian |
2.156600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15349960086542E-12 |
| Normal-vs-Female |
4.19210000046633E-07 |
| Male-vs-Female |
1.855140E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.023700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.74579964005306E-10 |
| Normal-vs-Age(61-80Yrs) |
9.49920031523277E-10 |
| Normal-vs-Age(81-100Yrs) |
4.596200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.946800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.486800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.281900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.068800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.923690E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.597350E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.689800E-02 |
| Normal-vs-Grade 2 |
2.8029000009866E-08 |
| Normal-vs-Grade 3 |
1.41340050774375E-10 |
| Normal-vs-Grade 4 |
6.14850000000278E-05 |
| Grade 1-vs-Grade 2 |
4.290200E-01 |
| Grade 1-vs-Grade 3 |
9.227400E-01 |
| Grade 1-vs-Grade 4 |
8.533500E-02 |
| Grade 2-vs-Grade 3 |
1.140010E-01 |
| Grade 2-vs-Grade 4 |
8.320800E-03 |
| Grade 3-vs-Grade 4 |
2.517600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.42320002846941E-09 |
| Normal-vs-ccB subtype |
3.67009977964017E-10 |
| ccA subtype-vs-ccB subtype |
2.858300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44070002991737E-10 |
| Normal-vs-N1 |
3.719800E-03 |
| N0-vs-N1 |
4.480400E-02 |
|
|
